All News

Clinical pharmacists were asked to provide interventions to improve their patients’ rate of not showing up to a pharmacy appointment.

Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.

The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.

Researchers conducted a survey asking pharmacists their perspectives on addressing patients’ social determinants of health.

Currently, there is a gap in treatment for this patient population and intracerebral hemorrhagic stroke is considered an orphan disease.

The approval is the first significant innovation for the delivery of epinephrine for this population in more than 35 years, according to the company news release.

Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients’ willingness to return for future immunization.

The main motivations for preferring vaccination included previous experience with an RSV infection and desire to protect the baby.

Researchers analyzed the association between adherence to a Mediterranean diet and obesity cancers, with a focus on the mediating role adiposity plays throughout the process.

All dosages of semaglutide (Wegovy) under the new program will be available at $499 per month for patients that are uninsured or who do not have coverage for obesity medication.

Investigators found that zonisamide was associated with a reduction in monthly migraine days for pediatric populations.

In a third installment of our interview series with Chris Robinson, MD, PhD, we looked at the future of pain management and emerging technologies being used for treatment.

“The Commission reinforces that obesity is a disease and not due to lack of motivation, willpower, discipline, or laziness,” Robert F. Kushner said.

Researchers determined the prevalence of weight management interventions among patients who were obese and received an obstructive sleep apnea diagnosis.

If CMS doesn’t reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.

Researchers explored the differences in off-label prescribing between pharmacists and physicians among a cohort of patients in pediatric palliative care.

Denosumab-Bmwo is approved for all indications of the respective reference products, including osteoporosis and high-risk of fracture due to chemotherapy.

However, investigators did not determine the association between compatibility status and loss-of-signal alarms.

In a search for new treatment and prevention strategies for pain in patients with fibromyalgia, researchers explored bioavailable nutraceuticals and phytochemicals like polyphenols.

A discussion with George Van Antwerp, MBA, senior vice president of Product Innovation and Strategic Planning at Prime Therapeutics.

GSK announced its ANCHOR-1 and ANCHOR-2 phase 3 trial results for depemokimab’s efficacy and safety in treating patients with chronic rhinosinusitis with nasal polyps.

Patients in the study could tolerate food allergens more, with fewer adverse events or reactions, compared with multi-allergen oral immunotherapy.

Physician, Public Health Expert & Former Amazon Pharmacy’s Chief Medical Officer to Deliver Keynote Address

Researchers explored out-of-pocket spending on maternity care and classified their findings by race and ethnicity.

Patients preferred ultrasound stimulation, followed by magnetic stimulation, drugs, electrical stimulation, and brain implantations.

Exploring data from the past 20 years, researchers investigated the end-organ complications from alcohol in adolescents and young adults.

A new study found that GLP-1s were not associated with an increased risk of suicidal ideation, self-harm, or suicide compared to DPP-4 and SGLT-2 inhibitors.

With the disease burden remaining high, CVS Health announces new flu testing and treatment capabilities at approximately 1600 locations in selected states.

Chris Robinson, MD, PhD, joined Drug Topics to discuss the importance of education in newly explored technologies for the treatment of pain.

Researchers compared hospitalization and mortality outcomes of older adults with and without restricted access to nirmatrelvir-ritonavir.